{"id":"https://openalex.org/W7225107779","doi":"https://doi.org/10.3389/fimmu.2026.1906848","title":"Anti-PD-L1 antibody limits the survival of activated CAR T cells by disrupting the PD-L1/CD80 cis-heterodimer","display_name":"Anti-PD-L1 antibody limits the survival of activated CAR T cells by disrupting the PD-L1/CD80 cis-heterodimer","publication_year":2026,"publication_date":"2026-11-02","ids":{"openalex":"https://openalex.org/W7225107779","doi":"https://doi.org/10.3389/fimmu.2026.1906848"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1906848","doi":"https://doi.org/10.3389/fimmu.2026.1906848","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1906848","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1906848/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1906848/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005703088","display_name":"Sin\u2010Syue Li","orcid":"https://orcid.org/0000-0003-0112-8324","observed_orcids":["https://orcid.org/0000-0003-0112-8324"]},"institutions":[{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]},{"id":"https://openalex.org/I4387153341","display_name":"Leibniz Institute for Immunotherapy","ror":"https://ror.org/00xn1pr13","country_code":"DE","type":"facility","lineage":["https://openalex.org/I315704651","https://openalex.org/I4387153341"]},{"id":"https://openalex.org/I91807558","display_name":"National Cheng Kung University","ror":"https://ror.org/01b8kcc49","country_code":"TW","type":"education","lineage":["https://openalex.org/I91807558"]}],"countries":["DE","TW"],"is_corresponding":false,"raw_author_name":"Sin-Syue Li","raw_affiliation_strings":["Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT)","Division of Hematology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University","Institute of Clinical Medicine, College of Medicine, National Cheng Kung University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT)","institution_ids":["https://openalex.org/I4387153341"]},{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University","institution_ids":["https://openalex.org/I4210158999","https://openalex.org/I91807558"]},{"raw_affiliation_string":"Institute of Clinical Medicine, College of Medicine, National Cheng Kung University","institution_ids":["https://openalex.org/I91807558"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042207171","display_name":"Markus Barden","orcid":"https://orcid.org/0000-0002-4923-2254","observed_orcids":["https://orcid.org/0000-0002-4923-2254"]},"institutions":[{"id":"https://openalex.org/I4387153341","display_name":"Leibniz Institute for Immunotherapy","ror":"https://ror.org/00xn1pr13","country_code":"DE","type":"facility","lineage":["https://openalex.org/I315704651","https://openalex.org/I4387153341"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Markus Barden","raw_affiliation_strings":["Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT)","institution_ids":["https://openalex.org/I4387153341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100664892","display_name":"Hong Pan","orcid":"https://orcid.org/0009-0001-0667-8213","observed_orcids":["https://orcid.org/0009-0001-0667-8213"]},"institutions":[{"id":"https://openalex.org/I4387153341","display_name":"Leibniz Institute for Immunotherapy","ror":"https://ror.org/00xn1pr13","country_code":"DE","type":"facility","lineage":["https://openalex.org/I315704651","https://openalex.org/I4387153341"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hong Pan","raw_affiliation_strings":["Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT)","institution_ids":["https://openalex.org/I4387153341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031218116","display_name":"Dennis Christoph Harrer","orcid":"https://orcid.org/0000-0001-7512-572X","observed_orcids":["https://orcid.org/0000-0001-7512-572X"]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4387153341","display_name":"Leibniz Institute for Immunotherapy","ror":"https://ror.org/00xn1pr13","country_code":"DE","type":"facility","lineage":["https://openalex.org/I315704651","https://openalex.org/I4387153341"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dennis Christoph Harrer","raw_affiliation_strings":["Department of Internal Medicine III - Hematology and Medical Oncology, University Hospital Regensburg","Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III - Hematology and Medical Oncology, University Hospital Regensburg","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT)","institution_ids":["https://openalex.org/I4387153341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077415726","display_name":"Marcell Kaljanac","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153341","display_name":"Leibniz Institute for Immunotherapy","ror":"https://ror.org/00xn1pr13","country_code":"DE","type":"facility","lineage":["https://openalex.org/I315704651","https://openalex.org/I4387153341"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Marcell Kaljanac","raw_affiliation_strings":["Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT)","institution_ids":["https://openalex.org/I4387153341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014651842","display_name":"Valerie Bezler","orcid":"https://orcid.org/0000-0003-0219-012X","observed_orcids":["https://orcid.org/0000-0003-0219-012X"]},"institutions":[{"id":"https://openalex.org/I4387153341","display_name":"Leibniz Institute for Immunotherapy","ror":"https://ror.org/00xn1pr13","country_code":"DE","type":"facility","lineage":["https://openalex.org/I315704651","https://openalex.org/I4387153341"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Valerie Bezler","raw_affiliation_strings":["Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT)","institution_ids":["https://openalex.org/I4387153341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001852496","display_name":"Moritz Ertelt","orcid":"https://orcid.org/0009-0004-2506-6660","observed_orcids":["https://orcid.org/0009-0004-2506-6660"]},"institutions":[{"id":"https://openalex.org/I4401726909","display_name":"Center for Scalable Data Analytics and Artificial Intelligence","ror":"https://ror.org/01t4ttr56","country_code":"DE","type":"education","lineage":["https://openalex.org/I4401726909","https://openalex.org/I78650965","https://openalex.org/I926574661"]},{"id":"https://openalex.org/I926574661","display_name":"Leipzig University","ror":"https://ror.org/03s7gtk40","country_code":"DE","type":"education","lineage":["https://openalex.org/I926574661"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Moritz Ertelt","raw_affiliation_strings":["Center for Scalable Data Analytics and Artificial Intelligence ScaDS.AI","Institute for Drug Discovery, University Leipzig Medicine Faculty"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Scalable Data Analytics and Artificial Intelligence ScaDS.AI","institution_ids":["https://openalex.org/I4401726909"]},{"raw_affiliation_string":"Institute for Drug Discovery, University Leipzig Medicine Faculty","institution_ids":["https://openalex.org/I926574661"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160338018","display_name":"Clara Schoeder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4401726909","display_name":"Center for Scalable Data Analytics and Artificial Intelligence","ror":"https://ror.org/01t4ttr56","country_code":"DE","type":"education","lineage":["https://openalex.org/I4401726909","https://openalex.org/I78650965","https://openalex.org/I926574661"]},{"id":"https://openalex.org/I926574661","display_name":"Leipzig University","ror":"https://ror.org/03s7gtk40","country_code":"DE","type":"education","lineage":["https://openalex.org/I926574661"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Clara Schoeder","raw_affiliation_strings":["Center for Scalable Data Analytics and Artificial Intelligence ScaDS.AI","Institute for Drug Discovery, University Leipzig Medicine Faculty"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Scalable Data Analytics and Artificial Intelligence ScaDS.AI","institution_ids":["https://openalex.org/I4401726909"]},{"raw_affiliation_string":"Institute for Drug Discovery, University Leipzig Medicine Faculty","institution_ids":["https://openalex.org/I926574661"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103612561","display_name":"Tsai-Yun Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]},{"id":"https://openalex.org/I91807558","display_name":"National Cheng Kung University","ror":"https://ror.org/01b8kcc49","country_code":"TW","type":"education","lineage":["https://openalex.org/I91807558"]}],"countries":["TW"],"is_corresponding":true,"raw_author_name":"Tsai-Yun Chen","raw_affiliation_strings":["Division of Hematology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University","institution_ids":["https://openalex.org/I4210158999","https://openalex.org/I91807558"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081176216","display_name":"Hinrich Abken","orcid":"https://orcid.org/0000-0002-4302-3240","observed_orcids":["https://orcid.org/0000-0002-4302-3240"]},"institutions":[{"id":"https://openalex.org/I4387153341","display_name":"Leibniz Institute for Immunotherapy","ror":"https://ror.org/00xn1pr13","country_code":"DE","type":"facility","lineage":["https://openalex.org/I315704651","https://openalex.org/I4387153341"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Hinrich Abken","raw_affiliation_strings":["Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT)","institution_ids":["https://openalex.org/I4387153341"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5081176216","https://openalex.org/A5103612561"],"corresponding_institution_ids":["https://openalex.org/I4210158999","https://openalex.org/I4387153341","https://openalex.org/I91807558"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.82091101,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6967999935150146,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6967999935150146,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.274399995803833,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.015200000256299973,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.8920000195503235},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.9100000262260437},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.8399999737739563},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9589999914169312},{"id":"https://openalex.org/keywords/cd80","display_name":"CD80","score":0.8080000281333923},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.949999988079071},{"id":"https://openalex.org/keywords/cd28-costimulation","display_name":"CD28 costimulation","score":0.972000002861023},{"id":"https://openalex.org/keywords/t-cell-survival","display_name":"T cell survival","score":0.8119999766349792},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.8579999804496765},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6669999957084656},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.5260000228881836},{"id":"https://openalex.org/keywords/4-1bb","display_name":"4-1BB","score":0.8510000109672546},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9290000200271606}],"concepts":[{"id":"https://openalex.org/C2778297628","wikidata":"https://www.wikidata.org/wiki/Q5009843","display_name":"CD80","level":5,"score":0.8331999778747559},{"id":"https://openalex.org/C148125776","wikidata":"https://www.wikidata.org/wiki/Q1622348","display_name":"CD28","level":4,"score":0.5223000049591064},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5103999972343445},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5008000135421753},{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.4814999997615814},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4749000072479248},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4715999960899353},{"id":"https://openalex.org/C2781101188","wikidata":"https://www.wikidata.org/wiki/Q5009846","display_name":"CD86","level":4,"score":0.47099998593330383},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.4537999927997589},{"id":"https://openalex.org/C49039625","wikidata":"https://www.wikidata.org/wiki/Q84230","display_name":"Secretion","level":2,"score":0.43709999322891235},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.4323999881744385},{"id":"https://openalex.org/C67662055","wikidata":"https://www.wikidata.org/wiki/Q1047791","display_name":"Antigen-presenting cell","level":4,"score":0.42649999260902405},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.41839998960494995},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.40470001101493835},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3968000113964081},{"id":"https://openalex.org/C2780405999","wikidata":"https://www.wikidata.org/wiki/Q3483597","display_name":"Co-stimulation","level":5,"score":0.38749998807907104},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3804999887943268},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3732999861240387},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.35690000653266907},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.3495999872684479},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.3416000008583069},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3409999907016754},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.3384000062942505},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.31189998984336853},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.3102000057697296},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.29899999499320984},{"id":"https://openalex.org/C33057221","wikidata":"https://www.wikidata.org/wiki/Q421580","display_name":"Diphtheria toxin","level":3,"score":0.29600000381469727},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.2921999990940094},{"id":"https://openalex.org/C129374314","wikidata":"https://www.wikidata.org/wiki/Q909381","display_name":"Interleukin 21","level":4,"score":0.28929999470710754},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.28040000796318054},{"id":"https://openalex.org/C113842279","wikidata":"https://www.wikidata.org/wiki/Q1873857","display_name":"Lymphoblast","level":3,"score":0.27619999647140503},{"id":"https://openalex.org/C49382859","wikidata":"https://www.wikidata.org/wiki/Q286498","display_name":"Lymphokine","level":3,"score":0.25529998540878296},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.25040000677108765},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.25029999017715454}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.3389/fimmu.2026.1906848","doi":"https://doi.org/10.3389/fimmu.2026.1906848","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1906848","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1906848/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:ce523b69a7fe429fbb8046e6a6293a88","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/ce523b69a7fe429fbb8046e6a6293a88","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1906848","doi":"https://doi.org/10.3389/fimmu.2026.1906848","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1906848","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1906848/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225107779.pdf","grobid_xml":"https://content.openalex.org/works/W7225107779.grobid-xml"},"referenced_works_count":54,"referenced_works":["https://openalex.org/W1135493307","https://openalex.org/W1749548564","https://openalex.org/W2000861313","https://openalex.org/W2016983859","https://openalex.org/W2022231632","https://openalex.org/W2087482409","https://openalex.org/W2112588707","https://openalex.org/W2130479394","https://openalex.org/W2504729294","https://openalex.org/W2516527638","https://openalex.org/W2566018578","https://openalex.org/W2734670400","https://openalex.org/W2746892915","https://openalex.org/W2761586559","https://openalex.org/W2773065484","https://openalex.org/W2806751609","https://openalex.org/W2851261758","https://openalex.org/W2886131798","https://openalex.org/W2936616584","https://openalex.org/W2949807431","https://openalex.org/W2966505016","https://openalex.org/W2971258927","https://openalex.org/W2991095295","https://openalex.org/W3009701405","https://openalex.org/W3036599100","https://openalex.org/W3087169700","https://openalex.org/W3122724341","https://openalex.org/W3123125599","https://openalex.org/W3141293077","https://openalex.org/W3153096965","https://openalex.org/W3158493996","https://openalex.org/W3163599487","https://openalex.org/W3188078179","https://openalex.org/W3198679689","https://openalex.org/W3202055454","https://openalex.org/W3205303985","https://openalex.org/W3214601102","https://openalex.org/W4200014243","https://openalex.org/W4200201081","https://openalex.org/W4200302294","https://openalex.org/W4210621547","https://openalex.org/W4283325152","https://openalex.org/W4286561135","https://openalex.org/W4309563010","https://openalex.org/W4318465547","https://openalex.org/W4363673745","https://openalex.org/W4365136415","https://openalex.org/W4376122028","https://openalex.org/W4380489720","https://openalex.org/W4387164156","https://openalex.org/W4388017059","https://openalex.org/W4388035659","https://openalex.org/W4393528900","https://openalex.org/W4394810127"],"related_works":["https://openalex.org/W2766674449","https://openalex.org/W2401368754","https://openalex.org/W2378501241","https://openalex.org/W2936616584","https://openalex.org/W2504729294","https://openalex.org/W2097707681","https://openalex.org/W2991095295","https://openalex.org/W7215096576","https://openalex.org/W2571091678","https://openalex.org/W2966505016"],"abstract_inverted_index":{"Chimeric":[0],"antigen":[1,89],"receptor":[2],"(CAR)":[3],"T":[4,36,61,83,94,113,141,174,188,204],"cells":[5,62,84,95,101,114,175],"have":[6],"revolutionized":[7],"the":[8,76,166],"treatment":[9],"of":[10,75],"hematologic":[11],"malignancies":[12],"but":[13],"remain":[14,49],"less":[15,86,97],"efficacious":[16],"in":[17,45,172],"solid":[18],"tumors.":[19],"While":[20],"PD-L1":[21,41,57,105,119,192,198],"blockade":[22,146,199],"is":[23,116,200],"widely":[24],"used":[25],"to":[26,124,191],"counter":[27],"tumor":[28],"immune":[29],"evasion,":[30],"its":[31],"direct":[32],"effects":[33],"on":[34,112],"activated":[35],"cells,":[37],"which":[38],"also":[39],"express":[40],"and":[42,91,106,127,140,152,169,176,180],"may":[43],"engage":[44],"PD-L1/CD80":[46,167],"cis":[47,110],"-interactions,":[48],"largely":[50],"unexplored.":[51],"To":[52],"investigate":[53],"this,":[54],"we":[55],"blocked":[56],"by":[58,118,159],"engineering":[59],"CAR":[60,82,93],"that":[63,115,163,194],"secrete":[64],"PD-L1-blocking":[65],"single-chain":[66],"variable":[67],"fragment":[68],"(scFv)":[69],"antibodies":[70],"derived":[71],"from":[72],"atezolizumab.":[73],"Secretion":[74],"scFv":[77],"conferred":[78],"no":[79],"benefit:":[80],"4-1BB-based":[81,181],"accumulated":[85],"upon":[87],"repeated":[88],"stimulation,":[90],"CD28-based":[92],"killed":[96],"efficiently":[98],"when":[99,197],"effector":[100],"were":[102,157,170],"limiting.":[103],"Mechanistically,":[104],"CD80":[107,122,138,150],"form":[108],"a":[109,187],"-heterodimer":[111],"disrupted":[117],"blockade,":[120],"rendering":[121],"susceptible":[123],"CTLA-4-mediated":[125],"depletion":[126],"impairing":[128],"CD28":[129],"co-stimulation.":[130],"Consistent":[131],"with":[132,147,202],"this":[133],"model,":[134],"exogenous":[135],"atezolizumab":[136,164],"reduced":[137],"expression":[139],"cell":[142,205],"viability,":[143],"while":[144],"CTLA-4":[145],"ipilimumab":[148],"restored":[149],"levels":[151],"rescued":[153],"survival.":[154],"These":[155],"findings":[156,185],"corroborated":[158],"structural":[160],"modeling":[161],"demonstrating":[162],"disrupts":[165],"complex,":[168],"reproduced":[171],"unmodified":[173],"across":[177],"both":[178],"CD28-":[179],"CARs.":[182],"Together,":[183],"our":[184],"uncover":[186],"cell-intrinsic":[189],"vulnerability":[190],"inhibitors":[193],"warrants":[195],"consideration":[196],"combined":[201],"adoptive":[203],"therapy.":[206]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-11-03T00:00:00"}